Cargando…
Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
PURPOSE: The COVID-19 pandemic’s impact on buprenorphine treatment for opioid use disorder among adolescents and young adults (AYAs) is unknown. METHODS: We used IQVIA Longitudinal Prescription Claims, including US AYAs aged 12–29 with at least 1 buprenorphine fill between January 2018 and August 20...
Autores principales: | Alinsky, Rachel H., Prichett, Laura, Chang, Hsien-Yen, Alexander, G. Caleb, Stein, Bradley D., Saloner, Brendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Adolescent Health and Medicine.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110275/ https://www.ncbi.nlm.nih.gov/pubmed/35595609 http://dx.doi.org/10.1016/j.jadohealth.2022.03.015 |
Ejemplares similares
-
29. Use of Buprenorphine for Opioid Use Disorder among US Adolescents and Young Adults During the COVID-19 Pandemic
por: Alinsky, Rachel, et al.
Publicado: (2022) -
Adolescent US Poison Center Exposure Calls During the COVID-19 Pandemic
por: Wang, George Sam, et al.
Publicado: (2022) -
Mental Healthcare Utilization, Modalities, and Disruptions During Spring 2021 of the COVID-19 Pandemic Among U.S. Adolescents
por: Campos-Castillo, Celeste, et al.
Publicado: (2022) -
The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care
por: Lin, Jessica A., et al.
Publicado: (2021) -
Understanding Perceived Risks and Sexual Behavior Among Adolescents and Young Adults During the COVID-19 Pandemic
por: Trent, Maria, et al.
Publicado: (2023)